Blueprint Medicines Corp buy melinda
Start price
14.12.16
/
50%
€23.36
Target price
05.01.17
€27.06
Performance (%)
16.56%
End price
05.01.17
€27.23
Summary
This prediction ended on 05.01.17 with a price of €27.23. The prediction had a final performance of 16.56%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Blueprint Medicines Corp | -1.945% | -1.945% | 101.619% | 45.919% |
iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by melinda for this prediction
In the thread Blueprint Medicines Corp diskutieren
folgen
a +
(Zielkurs erreicht)
Stopped prediction by melinda for Blueprint Medicines Corp
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€64.30
31.08.20
31.08.20
€66.00
04.11.21
04.11.21
55.52%
05.11.21
05.11.21
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€78.02
14.07.20
14.07.20
€100.00
31.08.20
31.08.20
-17.59%
31.08.20
31.08.20
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€76.30
26.05.19
26.05.19
€79.38
06.06.19
06.06.19
4.18%
06.06.19
06.06.19